Precigen (PGEN) Earnings Date & Reports

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PGEN is expected to report earnings to fall 104.60% to 0 cents per share on November 05

Q3'26

Est.

$0.00

Q2'26

Beat

by $0.06

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.01

Q3'25

Missed

by $0.97

The last earnings report on August 04 showed earnings per share of 5 cents, beating the estimate of 0 cents. With 1.36M shares outstanding, the current market capitalization sits at 2.54B.

View a ticker or compare two or three

PGEN

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days